Erysipeloid rash: A rare adverse event induced by gemcitabine

J Cancer Res Ther. 2015 Oct-Dec;11(4):1024. doi: 10.4103/0973-1482.148711.

Abstract

Some rare cases of erysipelas-like or pseudocellulitis have been reported in relation to gemcitabine. This rare adverse event is more frequent in the presence of edema. Here, we report a case of pseudocellulitis after adjuvant treatment for pancreatic cancer. Oncologists should be aware of this infrequent and non-well understood adverse event. They should be especially careful when administering gemcitabine in the presence of lymphedema.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / pathology
  • Adult
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Erysipeloid / chemically induced*
  • Erysipeloid / pathology
  • Exanthema / chemically induced*
  • Exanthema / pathology
  • Female
  • Gemcitabine
  • Humans
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / pathology
  • Prognosis
  • Rare Diseases / chemically induced*
  • Rare Diseases / pathology

Substances

  • Deoxycytidine
  • Gemcitabine